Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We have now added a new section called the "Assay History List" to the "At A Gla...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...